DNAG — DNAPrint Genomics Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.41m
- $2.43m
2002 December 31st | C2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.11 | -7.79 | -3.73 | -8.72 | -12.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.957 | 6.05 | 0.896 | 4.3 | 3.68 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.405 | 0.509 | -1.11 | 0.585 | 2.35 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -1.57 | -1.11 | -3.76 | -3.61 | -5.78 |
Capital Expenditures | -0.016 | -0.014 | -0.057 | -0.124 | -0.391 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.01 | 0 | -0.194 | -2.07 | 0.555 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.006 | -0.014 | -0.251 | -2.2 | 0.164 |
Financing Cash Flow Items | 0.085 | 0.238 | 0 | 0 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.55 | 1.38 | 4.73 | 6.63 | 4.41 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.031 | 0.254 | 0.713 | 0.828 | -1.21 |